Literature DB >> 1528440

Cerebrotendinous xanthomatosis: cranial CT and MRI studies in eight patients.

Y Hokezu1, M Kuriyama, R Kubota, M Nakagawa, J Fujiyama, M Osame.   

Abstract

We report the findings on cranial computed tomography (CT) and magnetic resonance imaging (MRI) and their correlation with the clinical manifestations, disease severity and biochemical abnormalities in eight patients with cerebrotendinous xanthomatosis. CT revealed cerebral atrophy in seven cases, cerebellar atrophy in four and focal low density lesions in the cerebral white matter in two. T2-weighted MRI showed high signal lesions in the cerebral white matter, focal in four cases and diffuse in one, and in the globus pallidus in three patients, two of whom also had lesions in the cerebellar white matter. While severely affected patients showed variable CT and MRI abnormalities, our cases did not show the dramatic findings expected from the neurological manifestations. Diffuse lesions in the cerebral and cerebellar white matter have been emphasized in previous reports, but in our study the focal lesions in the cerebral white matter were also present; the globus pallidus was frequently involved.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1528440     DOI: 10.1007/bf00588188

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  22 in total

1.  [Cerebrotendinous xanthomatosis. Apropos of a case using magnetic resonance study of the brain and nerve biopsy].

Authors:  H Amiel; R Gherardi; H Y Kanaan; J Buisson; R Genthon; J Zinszner; C Giroux; P Delaporte; J Salama
Journal:  Ann Med Interne (Paris)       Date:  1989

Review 2.  Cerebrotendinous xanthomatosis: clinical and biochemical evaluation of eight patients and review of the literature.

Authors:  M Kuriyama; J Fujiyama; H Yoshidome; S Takenaga; K Matsumuro; T Kasama; K Fukuda; T Kuramoto; T Hoshita; Y Seyama
Journal:  J Neurol Sci       Date:  1991-04       Impact factor: 3.181

3.  Cerebrotendinous xanthomatosis. Clinical and pathological studies.

Authors:  J R Schimschock; E C Alvord; P D Swanson
Journal:  Arch Neurol       Date:  1968-06

4.  Magnetic resonance imaging in cerebrotendinous xanthomatosis.

Authors:  P D Swanson; L D Cromwell
Journal:  Neurology       Date:  1986-01       Impact factor: 9.910

5.  Cerebrotendinous xanthomatosis in Hawaii--a therapeutic failure.

Authors:  R C Hinman
Journal:  Hawaii Med J       Date:  1984-12

6.  Computed tomography in cerebrotendinous xanthomatosis.

Authors:  V M Berginer; J Berginer; G Salen; S Shefer; R D Zimmerman
Journal:  Neurology       Date:  1981-11       Impact factor: 9.910

7.  Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid.

Authors:  V M Berginer; G Salen; S Shefer
Journal:  N Engl J Med       Date:  1984-12-27       Impact factor: 91.245

8.  Cerebrotendinous xanthomatosis (CTX): a clinical survey of the patient population in The Netherlands.

Authors:  R J Waterreus; B J Koopman; B G Wolthers; H J Oosterhuis
Journal:  Clin Neurol Neurosurg       Date:  1987       Impact factor: 1.876

9.  Cerebrotendinous xanthomatosis.

Authors:  S Y Hwang; K H Lee; J I Ahn
Journal:  J Dermatol       Date:  1990-02       Impact factor: 4.005

10.  Cerebrotendinous xanthomatosis: clinical and MRI study (a case report).

Authors:  M Fiorelli; V Di Piero; S Bastianello; L Bozzao; A Federico
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-01       Impact factor: 10.154

View more
  6 in total

1.  Cerebrotendinous xanthomatosis without tendon xanthomas mimicking Marinesco-Sjoegren syndrome: a case report.

Authors:  H R Siebner; S Berndt; B Conrad
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-05       Impact factor: 10.154

2.  The spectrum of magnetic resonance findings in cerebrotendinous xanthomatosis: redefinition and evidence of new markers of disease progression.

Authors:  Andrea Mignarri; Maria Teresa Dotti; Antonio Federico; Nicola De Stefano; Marco Battaglini; Irene Grazzini; Paolo Galluzzi; Lucia Monti
Journal:  J Neurol       Date:  2017-03-21       Impact factor: 4.849

3.  Gallium uptake in cerebrotendinous xanthomatosis.

Authors:  J Okada; H Oonishi; H Tamada; T Kizaki; K Yasumi; T Matuo
Journal:  Eur J Nucl Med       Date:  1995-09

Review 4.  Natural history of neurological abnormalities in cerebrotendinous xanthomatosis.

Authors:  Janice C Wong; Kailey Walsh; Douglas Hayden; Florian S Eichler
Journal:  J Inherit Metab Dis       Date:  2018-02-26       Impact factor: 4.982

5.  The neuropathology of cerebrotendinous xanthomatosis revisited: a case report and review of the literature.

Authors:  D Soffer; D Benharroch; V Berginer
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

6.  Symptomatic Bilateral Xanthogranuloma of the Choroid Plexus.

Authors:  Selin Tural Emon; Erek Ozturk; Kaan Meric; Fugen Aker; Metin Orakdogen
Journal:  J Neurosci Rural Pract       Date:  2017-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.